Voisin Consulting Life Sciences (VCLS), a contract research organization specializing in unmet medical needs and rare drug clinical trials, has selected Oracle Argus to enhance its global pharmacovigilance operations. The adoption of Oracle Argus will provide VCLS with advanced tools to support comprehensive pharmacovigilance services for its clients. Oracle Argus is recognized for its capabilities in processing, analyzing, and reporting adverse event cases across various medical products. This agreement is expected to help VCLS strengthen its safety services and meet complex regulatory requirements for a broad client base.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oracle Corporation published the original content used to generate this news brief on January 26, 2026, and is solely responsible for the information contained therein.